Hodgkin Lymphoma
From the Journals
Cancer risk elevated in hidradenitis suppurativa patients
Overall cancer risk and risk of several specific cancers was significantly higher among adults with hidradenitis suppurativa compared with...
Conference Coverage
Pembrolizumab prolonged PFS vs. brentuximab vedotin in r/r Hodgkin lymphoma
Pembrolizumab should be considered “the preferred treatment option and the standard of care” for patients with classic Hodgkin lymphoma not...
Conference Coverage
20% with cancer on checkpoint inhibitors get thyroid dysfunction
Researchers report more than double the rate of hypothyroidism and more than triple the rate of hyperthyroidism, compared with rates in published...
Conference Coverage
HIV free 30 months after stem cell transplant, is the London patient cured?
From the Journals
ECHELON-1 update: A+AVD bests ABVD in Hodgkin lymphoma
From the Journals
Adult survivors of childhood cancer are experiencing fewer major cardiac events
Reduced radiation exposure is a likely contributor to the improved cardiovascular outcomes.
From the Journals
Vitamin D deficiency appears to worsen survival in Hodgkin lymphoma
The researchers said vitamin D deficiency screening and replacement should be incorporated into future randomized clinical trials of Hodgkin...
From the Journals
Worse PFS when radiation is withheld in early-stage Hodgkin lymphoma
Patients negative for disease on PET scans after two chemotherapy cycles fared better with consolidation radiotherapy.
Conference Coverage
Cell count ratios appear to predict thromboembolism in lymphoma
AMSTERDAM – The findings mean clinicians can look to complete blood count for answers on thromboembolism risk.
From the Journals
Regimen shows promise as salvage for classical HL
Most patients studied responded to the regimen.
News
EC approves BV plus AVD for Hodgkin lymphoma
The approval for this indication is supported by the phase 3 ECHELON-1 trial.